Leading Companies - GCC Syringes And Needles Industry

Apr, 2023 - by CMI

Leading Companies - GCC Syringes And Needles Industry

 

The need for syringes and needles for illness detection and treatment rises with the incidence of chronic diseases including diabetes, cancer, cardiovascular diseases, and others, which is anticipated to fuel market expansion for syringes and needles throughout the forecast period. For instance, 73 million adults in the Middle East and North Africa (MENA) region, as reported in a December 2021 article by the International Diabetes Federation (IDF), have diabetes.  During the course of the forecast period, market expansion in the area is anticipated to be driven by the country's major players' increasing efforts, such as investments in the production of medical equipment for export. For instance, the U.A.E. allocated US$ 70 Mn in October 2022 for the production and international sale of medical equipment. A medical supply production line will be built in Abu Dhabi thanks to a partnership between PureHealth, a healthcare provider in the UAE, Abu Dhabi Medical Devices Company (ADMD), Abu Dhabi Ports Group, and polymers supplier Borouge.

Coherent Market Insights projects that the market for Syringes And Needles in the GCC is anticipated to reach US$ 252.3 million in 2022 and grow at a CAGR of 9.1% over the following five years (2022-2030).

Market Leaders in the GCC Syringes And Needles Industry:

1. Medtronic plc.

Medtronic, which was established there in 1949, has its headquarters in Minneapolis, Minnesota. It creates and produces medical technology and pharmaceuticals. A commercial decision to recall the HeartWare Ventricular Assist Device was made in February 2021. To satisfy the demand for care at ambulatory surgery centres, the company declared in April 2022 that it will collaborate with GE Healthcare. In October 2022, the company stated that it will investigate the possibility of splitting its integrated Patient Monitoring and Respiratory Interventions departments.

2. Becton

The business was established in 1897, with its headquarters in New Jersey, United States. The business produces and markets reagents, instrument systems, and medical equipment. Also, in some areas, BD provides advising and analytics solutions. A peripheral sirolimus drug-coated balloon first-in-human trial enrolment is set to begin in August 2022, according to the company (DCB).

3.  Nipro Corporation

The company was established in 1954 and has its headquarters in Osaka, Japan. Nipro Corporation produces pharmaceuticals. Equipment for artificial dialysis and blood transfusion, hypodermic syringes, and glass items for medical usage are among the company's offerings. NIPRO stated in July 2020 that it has acquired shares in an Indian provider of dialysis services.

4. Baxter International Inc.

The business was established in 1931 and has its headquarters in Illinois, United States. The business creates, produces, and sells goods and technologies for treating renal illness, trauma, immunological disorders, contagious diseases, haemophilia, and other acute and chronic medical ailments.  Baxter stated that it would buy Hill-rom for $12.4 billion in September 2021. The deal was finalised in December 2021 for $12.5 billion.

5.  B. Braun Melsungen AG, 

The company was founded in 1839 and Melsungen in central Germany serves as the company's headquarters. The business offers a variety of products and services in the health care industry, including those for surgical core procedures, emergency care, extracorporeal blood therapies, and intensive care units. In March 2022, the manufacturer of dialysis concentrates Intermedt Medizin & Technik GmbH was acquired by B. Braun.

6. Terumo Corporation

The firm was founded in 1921 and has its main office in Tokyo, Japan. Pharmaceuticals and medical supplies are produced and supplied by Terumo Corporation. Health foods, disposable medical supplies, clinical testing systems, artificial organs, and electronic thermometers are just a few of the company's offerings. Terumo said in December 2022 that a drug-device combination product that it co-developed with Kyowa Kirin would be released.

7. Smiths Group plc.

The firm was founded in 1851 and has its main office in London, United Kingdom. Smiths Group PLC offers goods and services for the energy, communications, medical equipment, threat and contraband detection, and markets. Smiths Group's medical segment was fully acquired by ICU Medical in January 2022.

*Definition: Needles and syringes are sterile instruments used to inject liquids into or remove secretions from the body. There are many different types and styles of syringes available. These are generally thrown out, and many of them have needles attached.

 

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.